Patient Square Capital’s argenx ARGX Stock Holding History

Patient Square Capital’s Portfolio ARGX Stock Details ARGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$21.3M	Sell	23,000 -13,718	-37%	-$11.3M	3.31%	7
2026 Q1	$26.8M	Buy	36,718 +10,718	+41%	+$8.39M	4.76%	2
2025 Q4	$21.9M	Buy	26,000 +10,500	+68%	+$8.99M	4.68%	4
2025 Q3	$11.4M	Sell	15,500 -13,500	-47%	-$8.9M	3.06%	6
2025 Q2	$16M	Buy	+29,000	New	+$16.8M	5.76%	3

Other funds holding ARGX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Patient Square Capital's ARGX Position: Q2 2026 in Review

Patient Square Capital reduced its argenx (ARGX) stake by 37% in Q2 2026, selling an estimated $11.3M and leaving 23,000 shares worth $21.3M. The position accounts for 3.31% of the portfolio, ranked #7.

Patient Square Capital first reported a position in ARGX in Q2 2025 and has held it in 5 quarters since. The position peaked at $26.8M in Q1 2026. 508 funds tracked by Wall St. Rank hold ARGX as of Q2 2026.

Patient Square Capital held 23,000 shares of argenx worth $21.3M as of Q2 2026.
Patient Square Capital sold 13,718 argenx shares in Q2 2026, an estimated $11.3M.
argenx made up 3.31% of Patient Square Capital's portfolio in Q2 2026, its #7 holding.
Patient Square Capital first reported a position in argenx in Q2 2025 and has held it in 5 quarters since.
Patient Square Capital's argenx position peaked at $26.8M in Q1 2026.
508 funds tracked by Wall St. Rank held argenx as of Q2 2026.

Based on Patient Square Capital's 13F filing for Q2 2026, filed 12 Aug 2026.